Amends TCA Title 33; Title 41; Title 53 and Title 63.
Tennessee SB0421 amends existing laws regarding the prescription of buprenorphine for opioid addiction treatment, allowing certain healthcare providers not licensed by the state medical boards to prescribe it under specific conditions. This bill affects healthcare providers working in state correctional facilities or jails who meet criteria such as having an active DEA registration and adopting clinical protocols for medication-assisted treatment. Key provisions include limitations on the number of patients they can prescribe to and requirements for collaboration with licensed physicians.
Tennessee SB0421 amends existing laws regarding the prescription of buprenorphine for opioid addiction treatment, allowing certain healthcare providers not licensed by the state medical boards to prescribe it under specific conditions. This bill affects healthcare providers working in state correctional facilities or jails who meet criteria such as having an active DEA registration and adopting clinical protocols for medication-assisted treatment. Key provisions include limitations on the number of patients they can prescribe to and requirements for collaboration with licensed physicians.
Track Tennessee Legislation Like a Pro
Join hundreds of professionals using LegisGo to stay ahead of legislative changes.
Instant Alerts
Get notified when bills you track move through the legislature
AI Summaries
Understand complex legislation in seconds with AI-powered analysis
Full Access
All 132 legislators, committee schedules, and voting records
Reeves, Shane
114th General Assembly
January 28, 2025
April 28, 2025
Comp. became Pub. Ch. 295